BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23673237)

  • 21. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
    Alexacou KM; Tenchiu Deleanu AC; Chrysina ED; Charavgi MD; Kostas ID; Zographos SE; Oikonomakos NG; Leonidas DD
    Bioorg Med Chem; 2010 Nov; 18(22):7911-22. PubMed ID: 20947361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, Kinetic and Conformational Studies of 2-Substituted-5-(β-d-glucopyranosyl)-pyrimidin-4-ones as Potential Inhibitors of Glycogen Phosphorylase.
    Mavreas KF; Neofytos DD; Chrysina ED; Venturini A; Gimisis T
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33266408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.
    Varga G; Docsa T; Gergely P; Juhász L; Somsák L
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1789-92. PubMed ID: 23395662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of synthetic methods for the preparation of N-beta-d-glucopyranosyl-N'-substituted ureas, -thioureas and related compounds.
    Somsák L; Felföldi N; Kónya B; Hüse C; Telepó K; Bokor E; Czifrák K
    Carbohydr Res; 2008 Aug; 343(12):2083-93. PubMed ID: 18299124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new glycosyl biuret and urea derivatives as potential glycoenzyme inhibitors.
    Felföldi N; Tóth M; Chrysina ED; Charavgi MD; Alexacou KM; Somsák L
    Carbohydr Res; 2010 Jan; 345(2):208-13. PubMed ID: 20004366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.
    Ullah H; Rahim F; Taha M; Uddin I; Wadood A; Shah SAA; Farooq RK; Nawaz M; Wahab Z; Khan KM
    Bioorg Chem; 2018 Aug; 78():58-67. PubMed ID: 29533215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
    Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
    Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.
    Liang Z; Zhang L; Li L; Liu J; Li H; Zhang L; Chen L; Cheng K; Zheng M; Wen X; Zhang P; Hao J; Gong Y; Zhang X; Zhu X; Chen J; Liu H; Jiang H; Luo C; Sun H
    Eur J Med Chem; 2011 Jun; 46(6):2011-21. PubMed ID: 21439694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.
    Wen X; Zhang P; Liu J; Zhang L; Wu X; Ni P; Sun H
    Bioorg Med Chem Lett; 2006 Feb; 16(3):722-6. PubMed ID: 16246555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.
    Kantsadi AL; Bokor É; Kun S; Stravodimos GA; Chatzileontiadou DSM; Leonidas DD; Juhász-Tóth É; Szakács A; Batta G; Docsa T; Gergely P; Somsák L
    Eur J Med Chem; 2016 Nov; 123():737-745. PubMed ID: 27522507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
    Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
    Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel dual-action antidiabetic agents that inhibit glycogen phosphorylase and activate glucokinase.
    Zhang L; Chen X; Liu J; Zhu Q; Leng Y; Luo X; Jiang H; Liu H
    Eur J Med Chem; 2012 Dec; 58():624-39. PubMed ID: 23178962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, thymidine phosphorylase inhibition and molecular modeling studies of 1,3,4-oxadiazole-2-thione derivatives.
    Shahzad SA; Yar M; Bajda M; Shahzadi L; Khan ZA; Naqvi SA; Mutahir S; Mahmood N; Khan KM
    Bioorg Chem; 2015 Jun; 60():37-41. PubMed ID: 25920005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.
    Kun S; Begum J; Kyriakis E; Stamati ECV; Barkas TA; Szennyes E; Bokor É; Szabó KE; Stravodimos GA; Sipos Á; Docsa T; Gergely P; Moffatt C; Patraskaki MS; Kokolaki MC; Gkerdi A; Skamnaki VT; Leonidas DD; Somsák L; Hayes JM
    Eur J Med Chem; 2018 Mar; 147():266-278. PubMed ID: 29453094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of anomeric sulfonamides and their behaviour under radical-mediated bromination conditions.
    Czifrák K; Somsák L
    Carbohydr Res; 2009 Feb; 344(3):269-77. PubMed ID: 19084827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and multiparametric evaluation of thiadiazoles and oxadiazoles as diacylglycerol acyltransferase type 1 inhibitors.
    Mougenot P; Namane C; Fett E; Goumy F; Dadji-Faïhun R; Langot G; Monseau C; Onofri B; Pacquet F; Pascal C; Crespin O; Ben-Hassine M; Ragot JL; Van-Pham T; Philippo C; Chatelain-Egger F; Péron P; Le Bail JC; Guillot E; Chamiot-Clerc P; Chabanaud MA; Pruniaux MP; Ménegotto J; Schmidt F; Venier O; Viviani F; Nicolai E
    Bioorg Med Chem Lett; 2016 Jan; 26(1):25-32. PubMed ID: 26627579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of some derivatives of C-(1-deoxy-1-N-substituted-D-glucopyranosyl)formic acid (D-gluco-hept-2-ulopyranosonic acid) as potential inhibitors of glycogen phosphorylase.
    Czifrák K; Kovács L; Kövér KE; Somsák L
    Carbohydr Res; 2005 Oct; 340(14):2328-34. PubMed ID: 16098956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the reversible enzyme reaction of rabbit muscle glycogen phosphorylase b using isothermal titration calorimetry.
    Szabó K; Kandra L; Gyémánt G
    Carbohydr Res; 2019 May; 477():58-65. PubMed ID: 31005807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing the β-pocket of the active site of human liver glycogen phosphorylase with 3-(C-β-d-glucopyranosyl)-5-(4-substituted-phenyl)-1, 2, 4-triazole inhibitors.
    Kyriakis E; Solovou TGA; Kun S; Czifrák K; Szőcs B; Juhász L; Bokor É; Stravodimos GA; Kantsadi AL; Chatzileontiadou DSM; Skamnaki VT; Somsák L; Leonidas DD
    Bioorg Chem; 2018 Apr; 77():485-493. PubMed ID: 29454281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
    Saitoh M; Kunitomo J; Kimura E; Hayase Y; Kobayashi H; Uchiyama N; Kawamoto T; Tanaka T; Mol CD; Dougan DR; Textor GS; Snell GP; Itoh F
    Bioorg Med Chem; 2009 Mar; 17(5):2017-29. PubMed ID: 19200745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.